Abacavir/Lamivudine
A VALIDATED STABILITY INDICATING RP HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF ABACAVIR, LAMIVUDINE AND DOLUTEGRAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
... of Abacavir, Lamivudine and Dolutegravir in bulk and pharmaceutical dosage ...of Lamivudine, Abacavir and Dolutegravir were found to be ...for Lamivudine, Abacavir and ...
24
“Development and Validation of Stability- Indicating Thin layer Chromatographic-Densitometric Determination of Abacavir,Lamivudine and Zidovudine in Bulk and Pharmaceutical Dosage Form” by Charushila H. Bhirud, Shivanand N.Hiremath, India.
... of Abacavir, Lamivudine and zidovudine in both as a bulk drug and in formulation was developed and validated as per the International Conference on Harmonization ...of Abacavir, Lamivudine and ...
5
Changes in Bone Mineral Density through 96 Weeks in Antiretroviral Naïve HIV 1 Infected Patients Receiving Abacavir/Lamivudine and Raltegravir in the SHIELD Trial
... Decreased bone mineral density (BMD) and osteoporotic fractures are areas of increasing concern among HIV-infected persons. Particular concern is the rapid decline in BMD after initiation of antiretroviral treatment ...
7
Simultaneous RP-HPLC determination of abacavir, lamivudine and dolutegravir in bulk API dosage forms
... using a mobile phase of Ammonium formate and methanol in the ratio of 40:60, at a flow rate of 0.8ml/minute. The analytes were monitored at 262nm using a PDA detector. The retention time of Abacavir, ...
8
DEVELOPMENT OF VALIDATED RP HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF ABACAVIR, LAMIVUDINE AND ZIDOVUDINE IN COMBINED TABLET DOSAGE FORM
... Purpose: To develop an accurate, simple and reproducible RP-HPLC method for the simultaneous estimation of abacavir, lamivudine and zidovudine in bulk drug and in combined tablet dosage form. Method: The ...
7
Virologic and Lipoprotein Changes after Halving Ritonavir Boosting in HIV Infected Patients Stabilized on Once Daily Fosamprenavir plus Abacavir/Lamivudine
... plus abacavir/lamivudine 300 mg/150 mg twice daily and showed that 69% of 322 antiretroviral-naïve patients treated were able to achieve a viral load <400 copies/mL at 48 weeks ...
8
A Randomized, Double-Blind Study of Triple Nucleoside Therapy of Abacavir, Lamivudine, and Zidovudine Versus Lamivudine and Zidovudine in Previously Treated Human Immunodeficiency Virus Type 1-Infected Children
... A Randomized, Double-Blind Study of Triple Nucleoside Therapy of Abacavir, Lamivudine, and Zidovudine Versus Lamivudine and Zidovudine in Previously Treated Human Immunodeficiency Virus.[r] ...
13
Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks
... Purpose: The 144-week results of the open-label, multicenter Atazanavir/Ritonavir Induction with Epzicom Study (ARIES) were stratified by gender to compare treatment responses. Methods: A total of 369 HIV-infected, ...
11
Simultaneous estimation of degree of crystallinity in combination drug product of abacavir, lamivudine and neverapine using X-ray powder diffraction technique
... The managing of human immunode fi ciency virus (HIV) includes the use of multiple antiretroviral, since single drug therapy becomes ineffective due to development of HIV resistant strains. According to treatment ...
6
Abacavir/lamivudine combination in the treatment of HIV: a review
... be efficacious in multiple studies. The flexibility of using this NRTI backbone with other classes is an additional advantage. Resistance mutations have not limited the clini- cal utility of this combination when used ...
12
Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany
... HLa-B*5701 screening prior to aBC/3tC fdC initiation prevents significant HsR-related costs per screened patient and is likely to lead to overall net sav- ings. Irrespective of economic considerations, there is a clear ...
7
hiv.12281.pdf
... This study, ASSURE (A Simplification Study of Unboosted Reyataz with Epzicom), investigated the efficacy and safety of discontinuing ritonavir in virologically suppressed par- ticipants receiving a regimen of ...
12
Development and Validation of Stability Indicating HPLC Method for Lamivudine, Zidovudine and Abacavir in Tablet Dosage Forms
... of Lamivudine, Zidovudine and Abacavir in active pharmaceutical ingredients and its dosage ...analogues Abacavir, Lamivudine and Zidovudine form one of the fixed dosage combinations used in ...
10
Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross sectional study
... 3TC: Abacavir/lamivudine; AIDS: Acquired Immunodeficiency Syndrome; aOR: Adjusted Odds Ratio; ART: Antiretroviral Therapy; ATV/r: Atazanavir/ ritonavir; AZT: Zidovudine; BMI: Body Mass Index; CI: Confidence ...
8
Simultaneous U V Spectrophotometric estimation of Lamivudine and Abacavir Sulphate in bulk and in tablet dosage form
... of Abacavir sulphate [3] . Spectrophotometric estimation of Lamivudine [4], Lamivudine in human plasma by RP-HPLC ...of Abacavir and Lamivudine in human plasma by ...of Abacavir, ...
7
Comparative efficacy and safety of dolutegravir relative to common core agents in treatment naïve patients infected with HIV 1: a systematic review and network meta analysis
... categories: abacavir/lamivudine (ABC/3TC), tenofovir disoproxil (or alafenamide) fumarate/emtricitabine (TD[A]F/FTC), or any other NRTI combination ...
14
Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations
... Abstract: The current standard of care for human immunodeficiency virus (HIV) treat- ment is a three-drug regimen containing a nonnucleoside reverse transcriptase inhibitor, a protease inhibitor, or an integrase strand ...
12
STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS ESTIMATION OF LAMIVUDINE, ABACAVIR AND DOLUTEGRAVIR FROM ITS TABLET DOSAGE FORM
... Abacavir, Lamivudine and some other antiretroviral drugs individually and in-combination with other ...of Abacavir, Lamivudine and Dolutegravir in bulk drug and pharmaceutical dosage ...
8
VALIDATED HPTLC METHOD FOR SIMULTANEOUS DETERMINATION OF LAMIVUDINE AND ABACAVIR SULPHATE IN TABLET DOSAGE FORM
... of Abacavir and Lamivudine in human plasma by LC/MS/MS 7 ...of Abacavir, Lamivudine, Zidovudine in pharmaceutical tablets human serum and in drug dissolution studies by HPLC 8 was also ...
5
Development and validation of an assay method for lamivudine and abacavir combined tablet formulation by RP-HPLC
... Potassium dihydrogen ortho phosphate, triethylamine, methanol, acetonitrile, water, lamivudine WRS (99.8%), abacavir sulphate WRS (99.7%), ABEC-L (labell claim 300 mg of lamivudine and 600mg of ...
7